- Patent Title: Expression vector encoding a Paenibacillus polymxa neutral protease
-
Application No.: US17386106Application Date: 2021-07-27
-
Publication No.: US11542489B2Publication Date: 2023-01-03
- Inventor: Thomas Greiner-Stoeffele , Stefan Schoenert
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Stinson LLP
- Priority: EP12175563 20120709
- Main IPC: C12N9/54
- IPC: C12N9/54 ; C12N15/31 ; C12N15/57 ; C12N1/19 ; C12N9/52 ; C07K14/195 ; C12N5/071

Abstract:
The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
Public/Granted literature
- US20210355472A1 METHODS OF RECOMBINANTLY PRODUCING NEUTRAL PROTEASE ORIGINATING FROM PAENIBACILLUS POLYMXA Public/Granted day:2021-11-18
Information query
IPC分类: